| The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens. | |
| | |
MedLine Citation:
|
PMID: 22535333 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
PURPOSE: We are trying to identify predictive factors of high risk of toxicity by analyzing candidate genes in the irinotecan pathways in order to identify useful tools to improve mCRC patient management under real practice conditions. METHODS: Genomic DNA was genotyped for UGT1A1 (*28, *60 and *93) from all 101 patients, and irinotecan dose was 180 mg/m(2) every second week. Clinical data were obtained by retrospective chart review. The primary endpoint is to find out whether the pharmacogenetic test in the clinical practice may predict toxicity. RESULTS: Grade 3/4 diarrhea occurred in twelve patients and required dose reduction in six patients, and neutropenia reached grade 3/4 in 19 patients (only one patient with *28/*28 genotype). The UGT1A1*93 seemed to relate with grade 3/4 neutropenia but only in the heterozygote state (G/A), p = 0.071, and UGT1A*60 showed no association with neutropenia. Twenty-eight percentage of patients required the use of G-CSF; 64.3 % of them harbored *1/*28 or *28/*28 genotypes, p = 0.003. Thirty-seven (36.6 %) patients required dose reduction of irinotecan and/or 5-FU owing to toxicity, mainly neutropenia and diarrhea. No significant association was detected between *28, *60 and *93 UGT1A variants and severe irinotecan-associated hematologic or GI toxicity. CONCLUSION: The impact of increased risk of toxicity attributed to the UGT1A variants may be offset by irinotecan in clinical practice by dose reduction or the use of colony-stimulating factor. |
| | |
Authors:
|
M J Lamas; G Duran; E Balboa; B Bernardez; S Candamio; Y Vidal; A Mosquera; J M Giraldez; R Lopez; A Carracedo; F Barros |
Related Documents
:
|
17597513 - The impact of different rehabilitation strategies after major events in the elderly: th... 16945723 - Radial longitudinal deficiency: the incidence of associated medical and musculoskeletal... 1397743 - Epidemiology and natural history of gastro-oesophageal reflux disease. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-4-26 |
Journal Detail:
|
Title: Cancer chemotherapy and pharmacology Volume: - ISSN: 1432-0843 ISO Abbreviation: - Publication Date: 2012 Apr |
Date Detail:
|
Created Date: 2012-4-26 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7806519 Medline TA: Cancer Chemother Pharmacol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Oncology Pharmacy Unit, Complejo Hospitalario Universitario of Santiago, Choupana S/N, 15706, Santiago de Compostela, Spain, mlamasd@yahoo.es. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.
Next Document: Association of p73 G4C14-A4T14 polymorphisms with genetic susceptibilities to breast cancer: a case-...